BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15283390)

  • 1. [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].
    Sciumè C; Geraci G; Pisello F; Li Volsi F; Facella T; Modica G
    Ann Ital Chir; 2004; 75(1):63-8; discussion 69. PubMed ID: 15283390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
    Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastric MALT lymphoma, clinical features].
    Udvardy M
    Orv Hetil; 1999 Feb; 140(6):291-4. PubMed ID: 10071508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
    J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
    Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
    Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary gastric lymphoma.
    Isaacson PG
    Br J Biomed Sci; 1995 Dec; 52(4):291-6. PubMed ID: 8555783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
    Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
    Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MALT-type low-grade B-cell lymphomas of the stomach and Helicobacter pylori].
    Binek J; Morant R; Weber A; Schmid U; Hammer B
    Schweiz Med Wochenschr; 1996 May; 126(19):841-4. PubMed ID: 8693310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
    Morgner A; Miehlke S; Fischbach W; Schmitt W; Müller-Hermelink H; Greiner A; Thiede C; Schetelig J; Neubauer A; Stolte M; Ehninger G; Bayerdörffer E
    J Clin Oncol; 2001 Apr; 19(7):2041-8. PubMed ID: 11283137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.
    Roggero E; Zucca E; Pinotti G; Pascarella A; Capella C; Savio A; Pedrinis E; Paterlini A; Venco A; Cavalli F
    Ann Intern Med; 1995 May; 122(10):767-9. PubMed ID: 7717599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric lymphoma and Helicobacter pylori.
    Isaacson PG; Spencer J
    Important Adv Oncol; 1996; ():111-21. PubMed ID: 8791131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
    Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E
    Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of a large gastric MALT lymphoma with antibiotic treatment to eradicate Helicobacter pylori.
    Martin J; Boyle S; Jacyna M
    Postgrad Med J; 1997 Feb; 73(856):109-10. PubMed ID: 9122089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
    tho Pesch S; Müller W; Borchard F; Peters U
    Z Gastroenterol; 1994 Dec; 32(12):684-7. PubMed ID: 7871859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
    Hiyama T; Haruma K; Kitadai Y; Ito M; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Sumii K; Shimamoto F; Chayama K
    Int J Oncol; 2001 Jun; 18(6):1207-12. PubMed ID: 11351252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.